ClinicalTrials.govpublic full text
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
pancreatic cancer, cetuximab, c225, erbitux, gemcitabine, oxaliplatin, eloxatin, capecitabine, xeloda, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803790
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.